Sulforaphane triggers Sirtuin 3-mediated ferroptosis in colorectal cancer cells via activating the adenosine 5‘-monophosphate (AMP)-activated protein kinase/ mechanistic target of rapamycin signaling pathway
Human & Experimental Toxicology · 2024
DOI: 10.1177/09603271241266106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human & Experimental Toxicology, 2024. Verfasst von Bo Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Xiangyang No. 1 People's Hospital, Hubei University of Medcine, Xiangyang, China. Hauptthemen laut MEDLINE: Isothiocyanates, Sirtuin 3, Sulfoxides, Colorectal Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
This study aimed to explore the expression and biological functions of SIRT3 in colorectal cancer cells (HCT-116), the impacts of sulforaphane on the ferroptosis of HCT-116 cells and the involvement of the SIRT3/AMPK/mTOR axis in those effects.
Methods
SIRT3-overexpressing (OE) and SIRT3-knockout (KO) cell lines were treated with different concentrations of sulforaphane, RSL-3, and IKE. Cell viability, intracellular ROS, MDA, iron levels, as well as mRNA and protein expressions of target genes were measured.
Results
SIRT3 expression in HCT-116 cells was increased by ferroptosis inducers and decreased by ferroptosis inhibitors. SIRT3 overexpression reduced cell viability and increased intracellular levels of ROS, MDA, and iron, whereas SIRT3 knockdown achieved the opposite effects. SIRT3 overexpression suppressed SLC7A11 expression and promoted the activation of AMPK/mTOR pathway. Restoration of SLC7A11 expression blocked the effects of SIRT3 on ferroptosis induction and cell viability inhibition. SIRT3 effects on cell viability and ferroptosis were antagonized by inhibitors of AMPK or mTOR. Moreover, sulforaphane triggered the ferroptosis of HCT-116 cells by activating the SIRT3/AMPK/mTOR axis.
Conclusions
SIRT3 triggered SLC7A11-mediated ferroptosis in HCT-116 cells, reducing cell viability by activating the AMPK/mTOR pathway, and sulforaphane targets it to inhibit colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Xiangyang No. 1 People's Hospital, Hubei University of Medcine, Xiangyang, China.
- Department of Gastroenterology, Xiangyang No. 1 People's Hospital Affiliated to Hubei University of Medicine, Xiangyang, China.
- Department of Ultrasound, Xiangyang No. 1 People's Hospital Affiliated to Hubei University of Medicine, Xiangyang, China.
- Department of Anaesthesia, Xiangyang No. 1 People's Hospital, Hubei University of Medcine, Xiangyang, China.
ORCID-Profile: Hui Yang
Zitieren
APA
Hu, B., Cao, P., Wang, J. H., Feng, W., Zhang, Y., & Yang, H. (2024). Sulforaphane triggers Sirtuin 3-mediated ferroptosis in colorectal cancer cells via activating the adenosine 5‘-monophosphate (AMP)-activated protein kinase/ mechanistic target of rapamycin signaling pathway. Human & Experimental Toxicology. https://doi.org/10.1177/09603271241266106
Vancouver
Hu B, Cao P, Wang JH, Feng W, Zhang Y, Yang H. Sulforaphane triggers Sirtuin 3-mediated ferroptosis in colorectal cancer cells via activating the adenosine 5‘-monophosphate (AMP)-activated protein kinase/ mechanistic target of rapamycin signaling pathway. Human & Experimental Toxicology. 2024. doi:10.1177/09603271241266106
BibTeX
@article{Hu2024,
author = {Hu, Bo and Cao, Ping and Wang, Jing-Hui and Feng, Wei and Zhang, Yang and Yang, Hui},
title = {Sulforaphane triggers Sirtuin 3-mediated ferroptosis in colorectal cancer cells via activating the adenosine 5‘-monophosphate (AMP)-activated protein kinase/ mechanistic target of rapamycin signaling pathway},
journal = {Human & Experimental Toxicology},
year = {2024},
doi = {10.1177/09603271241266106}
}
EUVIMED